Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Somaxon Pharmaceuticals Inc.

Division of Pernix Therapeutics Holdings Inc.
www.somaxon.com

Latest From Somaxon Pharmaceuticals Inc.

Pernix Reinvention Comes Down To Execution

Pernix has a new management team and a budding portfolio of CNS drugs, gained via M&A. Now the company needs to prove it can grow brands that compete in highly genericized markets and drive sustainable growth.

BioPharmaceutical Business Strategies

Biopharma Dealmaking Quarterly Statistics, Q3 2013

Biopharma financing in Q3 2013 totaled $4.6 billion, a 58% drop from the second quarter; Perrigo’s $8.3 billion acquisition of Elan made up more than half of the M&A dollar value; and marketed products made up the majority of licensed products.

BioPharmaceutical Deals

In Brief

Senate backs pre-tax OTC purchases; infirst Healthcare lands $38M investment; Star Scientific faces fraud allegation; Vitamin Shoppe franchise opens in Panama.

Consumer United States

People In Brief

Somaxon CEO moves to Apricus; Dr. Reddy’s founder dies; Spherix science director joins ABC board; Fitness entrepreneur Weider dies; Standard Process makes promotions.

Consumer United States
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Pernix Therapeutics Holdings Inc.
  • Senior Management
  • Richard W Pascoe, Pres. & CEO
    Tran B Nguyen, SVP & CFO
  • Contact Info
  • Somaxon Pharmaceuticals Inc.
    Phone: (858) 876-6500
    10935 Vista Sorrento Pkwy.
    Ste. 250
    San Diego, CA 92130
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register